Advertisement

European Journal of Dermatology

, Volume 27, Issue 6, pp 669–671 | Cite as

Clinical outcomes of primary cutaneous anaplastic large cell lymphoma: data from a single Japanese centre

  • Yuka Maruta
  • Toshihisa HamadaEmail author
  • Hiroko Fukamatsu
  • Tatsuya Kaji
  • Shin Morizane
  • Yoji Hirai
  • Tomoko Miyake
  • Osamu Yamasaki
  • Tadashi Yoshino
  • Keiji Iwatsuki
Correspondence
  • 13 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: A report from the Dutch Cutaneous Lymphoma Group on the long-term followup data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653–61.CrossRefGoogle Scholar
  2. 2.
    Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–85.CrossRefGoogle Scholar
  3. 3.
    Benner MF, Willemze R. Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma. Arch Dermatol 2009; 145: 1399–404.CrossRefGoogle Scholar
  4. 4.
    Woo DK, Jones CR, Vanoli-Storz MN, et al. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome. Arch Dermatol 2009; 145: 667–74.CrossRefGoogle Scholar
  5. 5.
    Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 479–84.CrossRefGoogle Scholar
  6. 6.
    Hamada T, Iwatsuki K. Cutaneous lymphoma in Japan: a nationwide study of 1733 patients. J Dermatol 2014; 41: 3–10.CrossRefGoogle Scholar
  7. 7.
    Hapgood G, Pickles T, Sehn LH, et al. Outcome of primary cutaneous anaplastic large cell lymphoma: A 20-year British Columbia Cancer Agency experience. Br J Haematol 2017; 176: 234–40.CrossRefGoogle Scholar
  8. 8.
    Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011; 118: 4024–35.CrossRefGoogle Scholar
  9. 9.
    Vergier B, Beylot-Barry M, Pulford K, et al. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol 1998; 22: 1192–202.CrossRefGoogle Scholar
  10. 10.
    Sugaya M, Fujita H, Izutsu K, et al. Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases. J Dermatol 2011; 38: 1009–12.CrossRefGoogle Scholar

Copyright information

© JLE/Springer 2018

Authors and Affiliations

  • Yuka Maruta
    • 1
  • Toshihisa Hamada
    • 1
    Email author
  • Hiroko Fukamatsu
    • 1
  • Tatsuya Kaji
    • 1
  • Shin Morizane
    • 1
  • Yoji Hirai
    • 1
  • Tomoko Miyake
    • 1
  • Osamu Yamasaki
    • 1
  • Tadashi Yoshino
    • 2
  • Keiji Iwatsuki
    • 1
  1. 1.Department of DermatologyOkayama University Graduate School of Medicine, Dentistry, and Pharmaceutical SciencesOkayamaJapan
  2. 2.Department of PathologyOkayama University Graduate School of Medicine, Dentistry, and Pharmaceutical SciencesOkayamaJapan

Personalised recommendations